Schedule

Subscribe to RSS Feed

2021
Thursday, May 27th
9:00 AM

Decreasing Post Insulin Hypoglycemia Incidence in End Stage Renal Disease (ESRD) patients

Anna Lo, MD, Thomas Jefferson University
Rachana Mundada, MD, Thomas Jefferson University
Eric Shiffrin, MD, Thomas Jefferson University
Jenny Wang, MD, Thomas Jefferson University

9:00 AM - 5:00 PM

Evaluating the Efficacy of a Nursing-Driven versus Provider-Driven Heparin Protocol

Naman Upadhyay, MD, Thomas Jefferson University
Joseph Soucy, MD, Thomas Jefferson University
Steven Manobianco, MD, Thomas Jefferson University
Samantha Sokoloff, MD, Thomas Jefferson University
Sairamya Bodempudi, MD, Thomas Jefferson University
Veda Pejaver, MD, Thomas Jefferson University
Max Ruge, MD, Thomas Jefferson University
Lynda Thomson, PharmD, Thomas Jefferson University
Lily Ackermann, MD, Thomas Jefferson University

9:00 AM - 5:00 PM

Improving Utilization of SGLT2 Inhibitors in the Inpatient Setting

Andrea Verghese, MD, Thomas Jefferson University
Bharaniabirami Rajaram, MD, Thomas Jefferson University
Fred Karaisz, MD, Thomas Jefferson University
Jason Ho, MD, Thomas Jefferson University
Kaya Patel, MD, Thomas Jefferson University
Michael Grodsky, MD, Thomas Jefferson University
Shifa Gandhi, MD, Thomas Jefferson University
Xuejun Wang, MD, Thomas Jefferson University
Yair Lev, MD, Thomas Jefferson University

9:00 AM - 5:00 PM

Medication Safety in the Operating Room

Tzvi Grossman, Thomas Jefferson University
Michael Glick, Thomas Jefferson University
Alexandra Mulholland, Thomas Jefferson University
Febina Padiyath, Thomas Jefferson University
Fred Balzer, Thomas Jefferson University

9:00 AM - 5:00 PM

Outpatient Mineralocorticoid Receptor Antagonist Prescription Rate for Heart Failure

Svenja Schneider, MD, Thomas Jefferson University
Sairamya Bodempudi, MD, Thomas Jefferson University
Joshua Bernard, MD, Thomas Jefferson University
Ryan D'Angelo, PharmD, Thomas Jefferson University
Eitan Frankel, MD, Thomas Jefferson University
Sara Collins, MD, Thomas Jefferson University
Yair Lev, MD, Thomas Jefferson University

9:00 AM - 5:00 PM

Tolerability of Switching Cholinesterase Inhibitors to Memantine Monotherapy Versus Adding Memantine as Combination Therapy for All-Cause Neurodegenerative Disorders

Estevana Isaac, MD, Thomas Jefferson University
Mijail Serruya, MD, PhD, Thomas Jefferson University
Keith Scott, PhD, Thomas Jefferson University
Michael R. Sperling, MD, Thomas Jefferson University
Carol Lippa, MD, Thomas Jefferson University

9:00 AM - 5:00 PM